These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38971758)

  • 1. CCDC88C, an O-GalNAc glycosylation substrate of GALNT6, drives breast cancer metastasis by promoting c-JUN-mediated CEMIP transcription.
    Deng B; Zhang S; Zhou Y; Sun T; Zhu Y; Fei J; Li A; Miao Y
    Cancer Cell Int; 2024 Jul; 24(1):237. PubMed ID: 38971758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
    Gao F; Zheng G
    Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GALNT6 suppresses progression of colorectal cancer.
    Duan J; Chen L; Gao H; Zhen T; Li H; Liang J; Zhang F; Shi H; Han A
    Am J Cancer Res; 2018; 8(12):2419-2435. PubMed ID: 30662801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
    Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
    Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway.
    Mao Y; Zhang Y; Fan S; Chen L; Tang L; Chen X; Lyu J
    Int J Biol Sci; 2019; 15(1):169-182. PubMed ID: 30662357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypeptide
    Guo Y; Shi J; Zhang J; Li H; Liu B; Guo H
    Onco Targets Ther; 2017; 10():3337-3344. PubMed ID: 28744137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
    Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
    Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.
    Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH
    Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway.
    Ding M; Liu J; Lv H; Zhu Y; Chen Y; Peng H; Fan S; Chen X
    Front Oncol; 2023; 13():1097772. PubMed ID: 36925932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
    Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
    Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
    Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
    Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer.
    Domanegg K; Sleeman JP; Schmaus A
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway.
    Xu G; Zhao L; Hua Q; Wang L; Liu H; Lin Z; Jin M; Wang J; Zhou P; Yang K; Wu G; Yu D; Zhang D; Zhang T
    Cell Death Dis; 2023 Feb; 14(2):167. PubMed ID: 36849460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer.
    Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MH
    Front Oncol; 2022; 12():802548. PubMed ID: 35692787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEMIP-mediated hyaluronan metabolism facilitates SCLC metastasis by activating TLR2/c-Src/ERK1/2 axis.
    Li L; Shen X; Mo X; Chen Z; Yu F; Mo X; Song J; Huang G; Liang K; Luo Z; Mao N; Yang J
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119451. PubMed ID: 36931608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALNT6 Knockdown Inhibits the Proliferation and Migration of Colorectal Cancer Cells and Increases the Sensitivity of Cancer Cells to 5-FU.
    Peng X; Chen X; Zhu X; Chen L
    J Cancer; 2021; 12(24):7413-7421. PubMed ID: 35003361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
    Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
    J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.